angiotensin ii has been researched along with Plasmodium falciparum Malaria in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, FL; Capurro, ML; de la Fuente-Nunez, C; de Sá Pinheiro, AA; Miranda, A; Oliveira, VX; Silva, AF; Silva, LS; Torres, MT | 1 |
| Alves, FL; Capurro, ML; Marcelo Der Torossian, T; Miranda, A; Silva, AF; Vani Xavier, O | 1 |
| Gallego-Delgado, J; Rodriguez, A; Walther, T | 1 |
| Caruso-Neves, C; da Silva-Filho, JL; de Sá Pinheiro, AA; de Souza Silva, L; Ferreira-DaSilva, CT; Henriques, Md; Perales, J; Saraiva, VB; Souza, MC; Teixeira-Ferreira, A | 1 |
4 other study(ies) available for angiotensin ii and Plasmodium falciparum Malaria
| Article | Year |
|---|---|
Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction.
Topics: Angiotensin II; Animals; Antimalarials; Chemical Engineering; Drug Design; Erythrocytes; Humans; Life Cycle Stages; Malaria, Falciparum; Peptides; Plasmodium falciparum; Plasmodium gallinaceum; Vasoconstriction; Vasodilator Agents | 2017 |
Highly potential antiplasmodial restricted peptides.
Topics: Aedes; Amino Acid Sequence; Angiotensin II; Animals; Antimalarials; Chickens; Humans; Malaria, Avian; Malaria, Falciparum; Molecular Sequence Data; Peptides; Plasmodium falciparum; Plasmodium gallinaceum | 2015 |
The High Blood Pressure-Malaria Protection Hypothesis.
Topics: Africa; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Asia; Causality; Disease Resistance; Drug Evaluation, Preclinical; Endemic Diseases; Endothelium, Vascular; Humans; Hypertension; Malaria, Cerebral; Malaria, Falciparum; Mice; Models, Biological; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prevalence; Receptor, Angiotensin, Type 2; Selection, Genetic | 2016 |
Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides.
Topics: Angiotensin I; Angiotensin II; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocytes; Humans; Life Cycle Stages; Malaria, Falciparum; Peptide Fragments; Peptides; Plasmodium falciparum; Rats; Renin-Angiotensin System; Schizonts | 2011 |